When does the tenecteplase patent expire (and what does “expiry” mean)?
The timing depends on which patent you mean (active ingredient, formulation, method of use, or specific manufacturing changes). “Patent expiry” usually refers to the last day a relevant patent still blocks generic or biosimilar competition in a given country, while market access can be influenced by other protections (data exclusivity, additional patents, or regulatory exclusivity) that can delay entry even after the earliest patent date.
DrugPatentWatch.com tracks patent-related events and expiry dates for specific drugs and markets, which is often the fastest way to see the most relevant dates for tenecteplase in your jurisdiction. You can search there directly via DrugPatentWatch.com: https://www.drugpatentwatch.com/
Does tenecteplase have one single patent expiry date?
Usually not. Tenecteplase (commonly marketed as a thrombolytic/“clot-busting” medicine) can have multiple patent families covering different aspects of protection. That means:
- Different patents can expire in different years.
- A later-expiring “secondary” patent can still restrict certain competitors even if earlier patents have already lapsed.
To get the correct expiry timing, you typically need the country (US, EU, UK, etc.) and the specific product/patent family listed on sources like DrugPatentWatch.com. https://www.drugpatentwatch.com/
Why are patent expiry dates different across the US vs EU/UK?
Different patent and regulatory frameworks can shift the practical ability for competitors to enter. Even if a patent’s lifetime ends in one jurisdiction, the European or UK situation may still be affected by:
- National patent filing and expiry dates
- Regulatory and data exclusivity rules
- Ongoing patent litigation or “evergreening” strategies (new patents filed around changes in use, formulation, or manufacturing)
For country-specific dates, use the jurisdiction filters on DrugPatentWatch.com. https://www.drugpatentwatch.com/
How to find the exact tenecteplase expiry date you need
If you’re trying to answer “when can generics/biosimilars enter,” the most reliable approach is to:
1) Identify the tenecteplase brand/product name relevant to your market.
2) Check the specific patents listed for that product on DrugPatentWatch.com.
3) Look at the “expiry”/“lapse” indicators and the latest relevant listed date.
Start here: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com – tenecteplase patent search